A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber

Clinical trial NCT00848965 · COMPLETED

Trial details

NCT number: NCT00848965
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rhinitis, Allergic, Perennial Allergic Rhinitis

Start date: 2007-10-01
Primary completion: 2008-01-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.